BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1177 related articles for article (PubMed ID: 31131050)

  • 1. "Navigate-dock-activate" anti-tumor strategy: Tumor micromilieu charge-switchable, hierarchically activated nanoplatform with ultrarapid tumor-tropic accumulation for trackable photothermal/chemotherapy.
    Cherukula K; Uthaman S; Park IK
    Theranostics; 2019; 9(9):2505-2525. PubMed ID: 31131050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-receptor-targeted laser-activable poly(lactide-
    Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
    Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel/IR1061-Co-Loaded Protein Nanoparticle for Tumor-Targeted and pH/NIR-II-Triggered Synergistic Photothermal-Chemotherapy.
    He L; Qing F; Li M; Lan D
    Int J Nanomedicine; 2020; 15():2337-2349. PubMed ID: 32308385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional Mesoporous Polydopamine With Hydrophobic Paclitaxel For Photoacoustic Imaging-Guided Chemo-Photothermal Synergistic Therapy.
    Zhang L; Yang P; Guo R; Sun J; Xie R; Yang W
    Int J Nanomedicine; 2019; 14():8647-8663. PubMed ID: 31806962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active Tumor Permeation and Uptake of Surface Charge-Switchable Theranostic Nanoparticles for Imaging-Guided Photothermal/Chemo Combinatorial Therapy.
    Hung CC; Huang WC; Lin YW; Yu TW; Chen HH; Lin SC; Chiang WH; Chiu HC
    Theranostics; 2016; 6(3):302-17. PubMed ID: 26909107
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Li C; Yang XQ; Zhang MZ; Song YY; Cheng K; An J; Zhang XS; Xuan Y; Liu B; Zhao YD
    Theranostics; 2018; 8(20):5662-5675. PubMed ID: 30555572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHI-148 Cyanine Dye Conjugated Chitosan Nanomicelle with NIR Light-Trigger Release Property as Cancer Targeting Theranostic Agent.
    Thomas RG; Moon MJ; Surendran SP; Park HJ; Park IK; Lee BI; Jeong YY
    Mol Imaging Biol; 2018 Aug; 20(4):533-543. PubMed ID: 29450802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bubble-generating polymersomes loaded with both indocyanine green and doxorubicin for effective chemotherapy combined with photothermal therapy.
    Zhu D; Fan F; Huang C; Zhang Z; Qin Y; Lu L; Wang H; Jin X; Zhao H; Yang H; Zhang C; Yang J; Liu Z; Sun H; Leng X; Kong D; Zhang L
    Acta Biomater; 2018 Jul; 75():386-397. PubMed ID: 29793073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
    Yang X; Shi X; Ji J; Zhai G
    Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-targeted delivery of paclitaxel and indocyanine green with aptamer-modified ferritin for synergetic chemo-phototherapy.
    Yang K; Dong Y; Li X; Wang F; Zhang Y
    Colloids Surf B Biointerfaces; 2023 Sep; 229():113437. PubMed ID: 37437411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomineralized Gd
    Hao T; Chen Q; Qi Y; Sun P; Chen D; Jiang W; Liu K; Sun H; Li L; Ding J; Li Z
    Adv Healthc Mater; 2019 Dec; 8(24):e1901005. PubMed ID: 31738019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HP-β-CD Functionalized Fe
    Song S; Chong Y; Fu H; Ning X; Shen H; Zhang Z
    ACS Appl Mater Interfaces; 2018 Oct; 10(40):33867-33878. PubMed ID: 30215249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed 'triple-mode' anti-tumor therapy: Improving peritoneal retention, tumor penetration and activatable drug release properties for effective inhibition of peritoneal carcinomatosis.
    Cherukula K; Bae WK; Lee JH; Park IK
    Biomaterials; 2018 Jul; 169():45-60. PubMed ID: 29631167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
    Hou L; Shan X; Hao L; Feng Q; Zhang Z
    Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICG/5-Fu coencapsulated temperature stimulus response nanogel drug delivery platform for chemo-photothermal/photodynamic synergetic therapy.
    Yao S; Jin X; Wang C; Cao A; Hu J; Chen B; Wang B
    J Biomater Appl; 2021 Oct; 36(4):565-578. PubMed ID: 33487068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
    Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
    Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Multimodal NIR-II Nanoprobe for the Detection of Metastatic Lymph Nodes and Targeting Chemo-Photothermal Therapy in Oral Squamous Cell Carcinoma.
    Wang Y; Zhang W; Sun P; Cai Y; Xu W; Fan Q; Hu Q; Han W
    Theranostics; 2019; 9(2):391-404. PubMed ID: 30809282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.